Celularity Inc (CELUW)
2025-06-30 | 2025-03-31 | |||
|---|---|---|---|---|
| Total net revenues | 5,736,000 | 11,426,000 | ||
| Amortization of acquired intangible assets | - | 368,000 | ||
| Selling, general and administrative | 12,634,000 | 14,262,000 | ||
| Research and development | 3,352,000 | 3,728,000 | ||
| Amortization of acquired intangible assets | 372,000 | - | ||
| Cost of revenues-Service | 220,000 | 209,000 | ||
| Cost of revenues-Product | 2,550,000 | 2,506,000 | ||
| Cost of revenues-License Royalty And Other | 2,472,000 | 839,000 | ||
| Total operating expenses | 21,600,000 | 21,912,000 | ||
| Loss from operations | -15,864,000 | -10,486,000 | ||
| Interest income | 62,000 | 76,000 | ||
| Interest expense | 1,943,000 | 2,437,000 | ||
| Loss on debt extinguishment | - | -5,736,000 | ||
| Change in fair value of warrant liabilities | 1,276,000 | -242,000 | ||
| Other expense, net | -4,428,000 | -1,401,000 | ||
| Change in fair value of debt | 1,075,000 | 12,000 | ||
| Total other (expense) income | -8,660,000 | -9,268,000 | ||
| Loss before income taxes | -24,524,000 | -19,754,000 | ||
| Income tax expense (benefit) | - | - | ||
| Net loss | -24,524,000 | -19,754,000 | ||
| Change in fair value of debt due to change in credit risk, net of tax | -3,000 | 5,000 | ||
| Comprehensive loss | -24,527,000 | -19,749,000 | ||
| Deemed dividend relating to inducement of dragasac warrants | - | 64,000 | ||
| Net loss attributable to common shareholders | -24,527,000 | -19,813,000 | ||
| Net loss per share - basic | -1.02 | -0.84 | ||
| Net loss per share - diluted | -1.02 | -0.84 | ||
| Weighted average shares outstanding - basic | 24,020,193 | 23,530,877 | ||
| Weighted average shares outstanding - diluted | 24,020,193 | 23,530,877 | ||